Revisit this year’s hottest topics, research and news in orthopedic biologics
Click Here to Manage Email Alerts
Healio highlights some of the most newsworthy research, topics and advancements in orthopedic biologic treatments in 202 3 .
Collaboration underway to advance future of biologics
As advancements in musculoskeletal biologic therapies have grown in the past decade, so has clinical use of these therapies despite insufficient evidence for widespread clinical application. Read more.
Clinical outcomes, biological analysis may provide understanding of responses to PRP
Integrating clinical outcomes with laboratory analysis of biological samples may lead to a better understanding of the variable responses to platelet-rich plasma therapy for musculoskeletal conditions. Read more.
Biologics may provide good imaging results for rotator cuff repair
Use of biologics in rotator cuff repair may provide good imaging results, but more research is needed on its impact on clinical outcomes. Read more.
VIDEO: More research required to identify PRP dosage, mechanism of action
Shane A. Shapiro, MD, discusses characterizing, dosing and investigating therapeutic mechanisms of action of platelet-rich plasma. Read more.
Speaker discusses modifiable factors that may impact PRP viability
In reviewing modifiable ways to optimize patients to receive platelet-rich plasma injections, Prathap Jayaram, MD, PhD, said some medications, such as NSAIDs, can have an effect growth factor expression. Read more.
Combined intraosseous bioplasty, meniscectomy may improve outcomes in patients with OA
Intraosseous bioplasty combined with arthroscopic meniscectomy may improve pain and outcome scores, as well as yield a low conversion rate to arthroplasty, in patients with mild to severe osteoarthritis. Read more.
VIDEO: Dragoo speaks about the future of orthobiologics
Jason L. Dragoo, MD, FAAOS, spoke about the next generation of orthobiologics at the American Association of Orthopaedic Surgeons Next Generation of Biologics Symposium. Read more.
VIDEO: Acellular implant may improve outcomes in patients with early arthritis
Use of an acellular implant made of aragonite may improve outcomes in patients with early arthritis compared with debridement or microfracture. Read more.